子宫内膜异位症患者腹腔液及血清中IL-12的水平测定

    Determination of interleukin-12 level in peritoneal fluid and serum of patients with endometriosis

    • 摘要: 目的:探讨子宫内膜异位症(EM)患者腹腔液及血清中白细胞介素-12(IL-12)水平的变化及意义。方法:采用ELISA法检测39例EM患者及16例非EM的对照者腹腔液及血清中IL-12水平。结果:EM组腹腔液及血清中IL-12水平均低于对照组(P<0.01)。EM组Ⅲ-Ⅳ期腹腔液IL-12(62.37±13.7)ng/L和血清IL-12(53.64±17.4)ng/L均低于Ⅰ-Ⅱ期患者腹腔液(76.38±13.5)ng/L和血清(75.67±12.3)ng/L水平(P<0.01)。结论:IL-12在EM发病中起重要作用,检测其含量变化对于该病的诊断治疗具有参考意义。

       

      Abstract: Objective:To explore the changes and clinical significance of interleukin-12 (IL-12) in the peritoneal fluid and serum of patients with endometriosis.Methods:IL-12 in the peritoneal fluid and serum of 39 patients with endometriosis and 16 controls were detected by enzyme linked immunosorbent assay (ELISA).Results:IL-12 levels in the peritoneal fluid and serum of the endometriosis group were lower than those of the control group (P<0.01).IL-12 levels in the peritoneal fluid(62.37±13.7) ng/L and in the serum(53.64±17.4) ng/L of patients with stageⅢ-Ⅳ endometriosis were lower than those in the peritoneal fluid(76.38±13.5) ng/Land in the serum(75.67±12.3) ng/L of patients with stageⅠ-Ⅱendometriosis (P<0.01).Conclusions:IL-12 may play an important role in the pathogenesis of endometriosis.Determining the IL-12 levels in patients with endometriosis could help to the diagnosis and treatment.

       

    /

    返回文章
    返回